新安股份(600596.SH)擬受讓並增資合肥星宇 取得其控股權
格隆匯1月11日丨新安股份(600596.SH)公佈,為豐富公司農藥品類,增強公司“除草專家、專業除草”的核心競爭力,公司擬出資總額不超過2.1億元,通過受讓部分原股東股權並增加註冊資本的方式,取得合肥星宇化學有限責任公司(以下簡稱:合肥星宇)51%以上的股份,納入公司合併報表範圍。
合肥星宇是一家專注於高品質農用化學品研製與開發的國家高新技術企業,擁有近百個原藥和製劑產品登記證,60項專利所有權和200多項商標所有權。主要產品包括除草劑、殺菌劑、殺蟲劑、種衣劑、肥料等,擁有生產規模及工藝技術全國領先的滅草松原藥生產線,並有多個原創技術產品在研。未來三年,合肥星宇在建項目的投產將為公司主營業務發展提供進一步有利支撐,擴大其在選擇性除草劑產品領域的領先競爭優勢。公司通過控股合肥星宇,將在產品鏈、銷售渠道上形成互補優勢,有利於公司豐富農用化學品品種,有利於公司進一步擴大除草劑等主導產品的競爭優勢,有利於公司實現原藥、製劑一體化發展,增強作物解決方案和農業全程服務能力,鞏固和提升公司行業領導者的地位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.